A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601
Public ClinicalTrials.gov record NCT01002820. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Treatment Protocol for Ganaxolone as add-on Therapy in Adult Patients With Uncontrolled Partial-onset Seizures Deriving Benefit From Protocol 1042-0601
Study identification
- NCT ID
- NCT01002820
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Marinus Pharmaceuticals
- Industry
- Enrollment
- 11 participants
Conditions and interventions
Conditions
Interventions
- ganaxolone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2009
- Primary completion
- Sep 30, 2010
- Completion
- Jul 31, 2013
- Last update posted
- Sep 6, 2022
2009 – 2013
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Southern California, Dept of Neurology | Los Angeles | California | 90033 | — |
| University of Kentucky, Dept of Neurology | Lexington | Kentucky | 40536 | — |
| Albany Medical Center, Dept of Neurology | Albany | New York | 12208 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Riddle Health Care Center II | Philadelphia | Pennsylvania | 19063 | — |
| Thomas Jefferson University, Comprehensive Epilepsy Center | Philadelphia | Pennsylvania | 19107 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01002820, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 6, 2022 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01002820 live on ClinicalTrials.gov.